The top penny stock gainer of 2017 has skyrocketed 513.87% so far this year, delivering a handsome return to its investors.
That soaring stock is Marinus Pharmaceuticals Inc., and its story illustrates what's so attractive about penny stocks as investments.
But investors should remember that penny stocks are risky. While these stocks have huge profit potentials, they also tend to see big pullbacks after making large gains.
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
If you're looking for the best penny stocks to buy today, you've come to the right place.
We're going to show you an easy way to determine whether or not a penny stock is safe for your money.
All you have to do is check out one important section of this publicly available document...
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
Investing in penny stocks today can be both safe and profitable if you do the right research.
That's why today we're going to show you one of the easiest ways to spot safe penny stocks.
Here's our tip - plus, one of the best small-cap stocks to buy right now...
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
Can I make money from penny stocks?
That's a question our readers have been asking, since penny stocks are extremely attractive for quick gains.
Here's one easy tip for finding safe - and profitable - penny stocks in 2017...
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
Finding the best biotech stocks to buy now can be exhausting, especially when investors have to read pages of technical jargon to find out what each company does.
That's why we've made it easy for Money Morning readers.
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
Our top pharmaceutical stocks to buy are all expected to have double-digit gains, making now a great time to buy.
With new drugs on the market, these companies have revenue coming in to fund pipeline developments. These pipeline developments will fuel revenue growth for years to come.
One of the stocks on our list is expected to gain as much as 172% in the next 12 months...
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
These 3 biotech stocks to watch are all positioned to rise with a common catalyst.
Analysts think this upcoming catalyst could cause one of these biotech stocks to gain nearly 140% in the next 12 months.
Here's what you need to watch with these biotech stocks in 2017...
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
We've put together a list of our top three best biotech stocks to buy now.
All three of them have a potential catalyst that could spur massive gains in the next year, and one of these biotech stocks could gain over 180% in 12 months.
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
Our expert has put together a set of biotech-buying guidelines to make finding the best biotech stocks to buy simple and profitable.
Using his guidelines, we've found three biotech stocks about to skyrocket.
One of them on our list could gain as much as 270% in the next 12 months...
Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
Tag Page Excerpt: These cheap biotech stocks to buy could gain as much as 180% in the next 12 months.
Their rapid stock price gains are largely due to the new drugs these companies are releasing.
Start the conversation